Metabolic Complications Using a Low- Versus High Concentration Citrate Solution for Regional Anticoagulation in Continuous Kidney Replacement Therapy.

NCT07751861 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

176

Enrollment

OTHER

Sponsor class

Conditions

Acute Kidney Injury

Interventions

DEVICE: low concentrated citrate solution (18 mmol/L)
DEVICE: high concentrated citrate solution (136 mmol/L)

Sponsor

University Hospital, Antwerp